Stay updated on Aducanumab in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page
- Check4 days agoChange DetectedThe page's revision history now shows a new revision entry (v3.5.5) and removes the previous revision (v3.5.4), indicating an updated page version.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays an updated revision label (v3.5.4) replacing the previous v3.5.3, indicating a newer page revision without changing substantive study content.SummaryDifference0.0%

- Check32 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan, Taiwan, 333 to Taoyuan County, Taiwan, 333, correcting the locality naming in the study's Contacts and Locations section. This change clarifies the geographic location of the site in the trial's location list.SummaryDifference0.0%

- Check47 days agoChange DetectedUpdates the displayed site revision identifier from **v3.5.2** to **v3.5.3** on the page footer.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Naples, Italy (postal codes 80131 and 80138) to the study locations and removed Napoli, Italy (postal codes 80131 and 80138).SummaryDifference0.0%

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.